Allspring Global Investments Holdings, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Allspring Global Investments Holdings, LLC

$59.4 Billion
Q2 2024

A detailed history of Allspring Global Investments Holdings, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 259 shares of ALNY stock, worth $69,409. This represents 0.0% of its overall portfolio holdings.

Number of Shares

259

Previous 168 54.17%

Holding current value

$69,409

Previous $25,000 148.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$143.31 - $247.0 $13,041 - $22,477	91 Added 54.17%	259 $62,000
Q1 2024 Apr 18, 2024	BUY	$146.51 - $198.2 $20,950 - $28,342	143 Added 572.0%	168 $25,000
Q4 2023 Jan 25, 2024	SELL	$151.41 - $196.57 $11.8 Million - $15.3 Million	-77,988 Reduced 99.97%	25 $4,000
Q3 2023 Oct 27, 2023	BUY	$170.77 - $211.65 $13.3 Million - $16.5 Million	78,013 New	78,013 $13.8 Million
Q2 2023 Jul 18, 2023	SELL	$185.01 - $212.05 $1.2 Million - $1.38 Million	-6,492 Reduced 18.88%	27,889 $5.3 Million
Q1 2023 Apr 13, 2023	SELL	$182.66 - $235.53 $527,339 - $679,975	-2,887 Reduced 7.75%	34,381 $6.89 Million
Q4 2022 Jan 23, 2023	SELL	$185.53 - $241.31 $45,640 - $59,362	-246 Reduced 0.66%	37,268 $0
Q3 2022 Oct 26, 2022	SELL	$138.54 - $232.0 $222,079 - $371,896	-1,603 Reduced 4.1%	37,514 $7.51 Million
Q2 2022 Jul 25, 2022	SELL	$120.42 - $169.29 $102,477 - $144,065	-851 Reduced 2.13%	39,117 $5.7 Million
Q1 2022 May 02, 2022	BUY	$127.18 - $173.91 $1.8 Million - $2.46 Million	14,121 Added 54.63%	39,968 $6.53 Million
Q4 2021 Jan 28, 2022	BUY	$159.56 - $209.29 $4.12 Million - $5.41 Million	25,847 New	25,847 $4.38 Million

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account

Allspring Global Investments Holdings, LLC Alnylam Pharmaceuticals, Inc. Transaction History